CHARACTERIZATION OF THEOPHYLLINE METABOLISM BY HUMAN-LIVER MICROSOMES - INHIBITION AND IMMUNOCHEMICAL STUDIES

被引：133
作者：
ROBSON, RA
MINERS, JO
MATTHEWS, AP
STUPANS, I
MELLER, D
MCMANUS, ME
BIRKETT, DJ
机构：
来源：
BIOCHEMICAL PHARMACOLOGY | 1988年 / 37卷 / 09期
关键词：
D O I：
10.1016/0006-2952(88)90423-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1651 / 1659
页数：9
相关论文
共 33 条
[1]   INTERACTION OF PROPOXYPHENE WITH DIAZEPAM, ALPRAZOLAM AND LORAZEPAM [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
MORSE, DS ;
SHADER, RI .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (01) :51-57
[2]   CHANGES IN ANTIPYRINE AND INDOCYANINE GREEN KINETICS DURING NIFEDIPINE, VERAPAMIL, AND DILTIAZEM THERAPY [J].
BAUER, LA ;
STENWALL, M ;
HORN, JR ;
DAVIS, R ;
OPHEIM, K ;
GREENE, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (02) :239-242
[3]   EVIDENCE FOR A DUAL ACTION OF SULPHINPYRAZONE ON DRUG-METABOLISM IN MAN - THEOPHYLLINE-SULPHINPYRAZONE INTERACTION [J].
BIRKETT, DJ ;
MINERS, JO ;
ATTWOOD, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (05) :567-569
[4]   SECONDARY METABOLISM OF THEOPHYLLINE BIOTRANSFORMATION PRODUCTS IN MAN - ROUTE OF FORMATION OF 1-METHYLURIC ACID [J].
BIRKETT, DJ ;
MINERS, JO ;
ATTWOOD, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (01) :117-119
[5]  
BIRKETT DJ, 1985, ANTIASTHMA XANTHINES, P230
[6]  
BURNAKIS TG, 1983, CLIN PHARMACY, V2, P458
[7]   THEOPHYLLINE METABOLISM IN RELATION TO ANTIPYRINE, DEBRISOQUINE, AND SPARTEINE METABOLISM [J].
DAHLQVIST, R ;
BERTILSSON, L ;
BIRKETT, DJ ;
EICHELBAUM, M ;
SAWE, J ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) :815-821
[8]  
DAM M, 1977, LANCET, V2, P509
[9]   DIFFERENTIAL-EFFECTS OF CIMETIDINE ON THEOPHYLLINE METABOLIC PATHWAYS [J].
GRYGIEL, JJ ;
MINERS, JO ;
DREW, R ;
BIRKETT, DJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (03) :335-340
[10]   CIGARETTE-SMOKING AND THEOPHYLLINE CLEARANCE AND METABOLISM [J].
GRYGIEL, JJ ;
BIRKETT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (04) :491-496
1234